| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Prilocaine hydrochloride 4% dental cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Prilocaine hydrochloride 1% injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Prilocaine hydrochloride 4% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Product containing prilocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Prilocaine hydrochloride 4%/epinephrine 200,000 injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Epinephrine 5mcg/prilocaine hydrochloride 40mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Prilocaine hydrochloride 4% injection solution 1.8mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
| Product containing precisely prilocaine hydrochloride 80 milligram/2 milliliter conventional release solution for injection cartridge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prilocaine hydrochloride 80 milligram/2 milliliter conventional release solution for injection cartridge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely felypressin 0.06 unit/2 milliliter and prilocaine hydrochloride 60 milligram/2 milliliter conventional release solution for injection cartridge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely felypressin 0.06 unit/2 milliliter and prilocaine hydrochloride 60 milligram/2 milliliter conventional release solution for injection cartridge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely felypressin 0.03 unit/1 milliliter and prilocaine hydrochloride 30 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely felypressin 0.03 unit/1 milliliter and prilocaine hydrochloride 30 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prilocaine hydrochloride 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prilocaine hydrochloride 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prilocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely prilocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]